Design, development, and performance of a novel multidose dry-powder inhaler

Pharmaceutical Technology

Volumn 23, Issue 10, 1999, Pages 70-81

  Parry Billings, M ^a   Boyes, R N ^b   Clisby, L M ^b   Braithwaite, P ^c   Williams, S ^c   Harper, A E ^b  

^a Innovata Biomed Ltd   (United Kingdom)

^b ML Laboratories PLC ^*  (United Kingdom)

^c Innovata Biomed Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; SALBUTAMOL;

ASTHMA; BREATHING PATTERN; COMPUTER AIDED DESIGN; DRUG DELIVERY SYSTEM; HUMAN; POWDER INHALER; REVIEW;

EID: 0032717451     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. United Nations Environment Program (UNEP), "Montreal Protocol on Substances That Deplete the Ozone Layer," in Technology and Assessment Panel Report, Vol. I and II (UNEP, The Netherlands, 1997).
2. "Chlorofluorocarbon Propellants in Self-Pressurized Containers; Determinations That Uses Are No Longer Essential; Request for Comments," Federal Register 62 (44), 10242-10246 (1997).
3. B. Jamieson, "Your Metered-Dose Inhaler Will Be Changing," Allergy 53, 3-4 (1998).
4. J. Bell, "International Development of Portable Inhalers," J. Invest. Allergol. Clin. Immunol. 7 (5), 417-419 (1997).
5. S. Pedersen, L. Frost, and T. Arnfred, "Errors in Inhalation Technique and Efficiency in Inhaler Use in Asthmatic Children," Allergy 41 (2), 118-124 (1986).
6. G.K. Crompton, "Problems Patients Have Using Pressurised Aerosol Inhalers," Eur. J. Respir. Dis. 63 (s119), 101-104 (1982).
7. I.J. Smith, "The Challenge of Reformulation," J. Aerosol Sci. 8 (s1), S19-S27 (1995).
8. R.E.C. Altounyan, "Inhibition of Experimental Asthma by a New Compound - Disodium Cromoglycate 'Intal'," Acta Allergologica 22 (6), 487-489 (1967).
9. A. Brindley et al., "Design, Manufacture and Dose Consistency of the Serevent Diskus Inhaler," Pharm. Technol. Eur. 7 (1), 14-22 (1995).
10. K. Wetterlin, "Turbuhaler: A New Powder Inhaler for Administration of Drugs to the Airways," Pharm. Res. 5, 506-508 (1988).
11. P.M. O'Byme, "Clinical Comparisons of Inhaler Systems: What Are the Important Aspects?" J. Aerosol Med. 8 (s3), S39-S46 (1995).
12. M.P. Timsina et al., "Drug Delivery to the Respiratory Tract Using Dry-Powder Inhalers," Int J. Pharm. 101, 1-13 (1994).
13. D. Ganderton, "General Factors Influencing Drug Delivery to the Lung," Resp. Med. 91 (supplement A), 13-16 (1997).
14. FDA, Guidance for Industry - Metered-Dose Inhaler and Dry-Powder Inhaler Drug Products (FDA, Rockville, MD, 1998).
15. "Growth Opportunites for Losec," Scrip 2081, 22 (28 November 1995).
16. British Thoracic Society, "Guidelines on Asthma Management," Thorax 52 (s1), S1-S21 (1997).
17. National Heart, Lung, and Blood Institute of the National Institutes of Health, "International Consensus Report on Diagnosis and Treatment of Asthma," Eur. Respir. J. 5 (5), 601-641 (1992).
18. National Heart, Lung, and Blood Institute of the National Institutes of Health, "Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention," in NHLBI/WHO Workshop Report (US Department of Health and Human Services, Bethesda, MD, 1995).
19. J. Barrowcliffe et al., "The In Vitro Evaluation of a Novel Multi-Dose Dry-Powder Inhaler," in Drug Delivery to the Lungs VII (The Aerosol Society, London, 1996), pp. 82-85.
20. J. Barrowcliffe et al., "Beclomethasone Dipropionate (BDP) Clickhaler: In Vitro Performance of a Steroid Novel Dry-Powder Inhaler," in Drug Delivery to the Lungs VIII (The Aerosol Society, London, 1997), pp. 125-128.
21. P. McGlynn et al., "Consistent In Vitro Dose Delivery from a Novel Beclomethasone Dipropionate Dry-Powder Inhaler (Clickhaler)," in Drug Delivery to the Lungs IX (The Aerosol Society, London, 1998), pp. 88-91.
22. Data on file, Innovata Biomed, Ltd., St. Albans, Hertfordshire, UK.
23. M. Parry-Billings, "In Vitro Performance of a Novel Multidose Dry-Powder Inhaler Following a Period of Routine Clinical Use," in Respiratory Drug Delivery: V, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm Press, Inc., Buffalo Grove, IL, 1996), pp. 400-401.
24. A.H. Morice et al., "Comparison of the Efficacy of Salbutamol Delivered via a Novel Multidose Dry-Powder Inhaler or Metered-Dose Inhaler before and after a Period of Routine Clinical Use," in Respiratory Drug Delivery: V, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm Press, Inc., Buffalo Grove, IL, 1996), pp. 380-381.
25. M.T. Newhouse et al., "Clickhaler (a Novel DPI) Provides Similar Bronchodilation to pMDI, Even at Low Flow Rates," Chest 115, 952-956 (1999).
26. C. O'Callaghan et al., "Efficacy and Safety of Salbutamol Delivered by a Novel Multidose Dry-Powder Inhaler (DPI) and a Pressurised Metered-Dose Inhaler (MDI) in Paediatric Asthma," Eur. Respir. J. 10 (s25), 126S (1997).
27. A.H. Morice, J. Stradling, and N.C. Barnes, "Assessment of the Acceptability of a New Multidose Dry-Powder Inhaler in Patients with Asthma," Eur. Respir. J. 10 (s25), 126S (1997).
28. M. Kindle and H. Chrystyn, "Determination of the Relative Bioavailability of Salbutamol to the Lung Following Inhalation," Br. J. Pharmacol. 34 (4), 311-315 (1992).
29. J.K. Chege, M. Parry-Billings, and H. Chrystyn, "Relative Bioavailability of Salbutamol to the Lung Following Inhalation via Two Versions of a Novel Dry-Powder Inhaler (Clickhaler) and a Standard Pressurized Metered-Dose Inhaler (Ventolin)," Pharm. Pharmacol. Commun. 4 (supplement), 107-109 (1998).
30. J.K. Chege and H. Chrystyn, "Salbutamol Lung Deposition Is Dependent on Inhalation Rate and Formulation," J. Pharm. Pharmacol. 47 (12), 1098 (1995).
31. S.J. Warren and G. Taylor, "Effect of Inhalation Flow Profiles on the Deposition of Radiolabelled BDP from a Novel Dry-Powder Inhaler (DPI, Clickhaler), a Conventional Metered-Dose Inhaler (MDI), and MDI Plus Spacer," in Respiratory Drug Delivery: VI, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm Press, Inc., Buffalo Grove, IL, 1998), pp. 453-455.
32. S.J. Warren, A.M. Rowe, and G. Taylor, "Efficient Lung Deposition of Beclomethasone Dipropionate (BDP) via a Novel Multidose Dry-Powder Inhaler Compared to a Conventional Pressurised Metered Dose Inhaler," Pharm. Res. 14 (s11), S131 (1997).
33. S.J. Warren, A.M. Rowe, and G. Taylor, "Comparison of the Lung Deposition of Radiolabelled Beclomethasone Dipropionate (BDP) from a Novel Dry-Powder Inhaler (DPI), Conventional Pressurised Metered-Dose Inhaler (MDI), and MDI with a Spacer Attachment," Thorax 52 (s6), A81 (1997).
34. S.J. Warren and G. Taylor, "Gamma Scintigraphic Evaluation of a Novel Budesonide Dry-Powder Inhaler (Clickhaler)," Pharm. Sci. 1 (1), S-208 (1998).
35. S.P. Newman, "Scintigraphic Assessment of Pulmonary Delivery Systems," Pharm. Technol. 22 (6), 78-94 (1998).
36. A.H. Morice et al., "Use of Whole-Body Plethysmography to Compare Bronchodilator Inhaler Efficacy," Respiration 65 (2), 12-124 (1998).
37. A.H. Morice et al., "Reproducibility of Bronchodilator Response for a Reservoir Dry-Powder Inhaler Following Routine Clinical Use," J. Asthma (in press).
38. P.J. Sterk et al., "Official Statement of the European Respiratory Society: Report Working Party Standardisation of Lung Function Tests European Community for Steel and Coal. Airway Responsiveness: Standardised Challenge Testing with Pharmacological, Physical and Sensitising Stimuli in Adults," Eur. Respir. J. 6 (s16), 53-83 (1993).
39. B. Andrews, A.H. Morice, and M. Taylor, "Beclomethasone Dipropionate (DBP) Delivered via a Novel Dry-Powder Inhaler (DPI) Reduces Bronchial Hyperresponsiveness," Eur. Respir. J. 12 (s28), 67s (1998).
40. J. Ayres and G. Laszlo, "Efficacy and Safety of a Novel Beclomethasone Dipropionate (BDP) Dry-Powder Inhaler (DPI)," Eur. Respir. J. 12 (s28), 67s (1998).
41. L.M. Adler and I.C. Clarke, "Efficacy and Safety of Beclomethasone Dipropionate (BDP) Delivered via a Novel Dry-Powder Inhaler (Clickhaler) in Paediatric Patients with Asthma," Thorax 52 (s6), A57 (1997).